Share Price | Triochem Products Ltd Stock Analysis & Recommendation

Q: Why is Triochem Products Ltd falling/rising?

As of 01-Sep, the stock price of Triochem Products Ltd is currently at 17.40, with no change from the previous trading session. The stock has shown a performance of 0.00% over the past week and month, indicating stability in its price despite the broader market trends. However, it has underperformed significantly compared to the sector, with a performance today that is down by 99.34%. Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a bearish trend. The erratic trading pattern, where the stock did not trade on 5 out of the last 20 days, further indicates a lack of consistent investor interest. While the BSE Small Cap index has gained by 1.42%, Triochem Products Ltd has not benefited from this upward movement, contributing to its stagnant price. Overall, the combination of underperformance against the sector, trading below moving averages, and erratic trading behavior suggests that the stock is currently in a falling trend.

Q: Who are in the management team of Triochem Product?

The management team of Triochem Product includes the following individuals:1. Ramu S Deora - Director & Chief Executive Officer2. Sunil S Jhunjhunwala - Independent Director3. S S Sharma - Director4. Girish Kumar Pungalia - Independent Director5. Rajesh Ramu Deora - Director6. Ureca Shirish Shirole - Company Secretary & Compliance Officer7. Grace R. Deora - Non-Executive DirectorIf you have any more questions about the company or its management, feel free to ask!

Q: What does Triochem Product do?

Overview:Triochem Products Ltd is engaged in the manufacturing and exporting of pharmaceutical products, APIs, and chemicals, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.History:Triochem Products Ltd was incorporated on January 17, 1972. The latest quarterly results reported are for June 2026, showing a net profit of 0 Cr.Financial Snapshot:Most recent Net Sales: N/AMost recent Net Profit: 0 Cr (Quarterly Results - Jun 2026)Market-cap value: INR Cr (Micro Cap)Key Metrics:Industry P/E: N/ADividend Yield: 0.00%Debt Equity: 0.00Return on Equity: 0.00%Price to Book: 0.00Contact Details:Address: Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001Phone: 91-22-22663150Email: investor@triochemproducts.comWebsite: http://www.triochemproducts.com

Q: Who are the peers of the Triochem Product?

Peers: The peers of Triochem Product are Unjha Formul., Ortin Global, Beryl Drugs, Brawn Biotech, Ganga Pharma., Vivanza Biosci., Decipher Labs, Shyama Computro., and Fabino Enter.Quality Snapshot: Excellent management risk is observed at Unjha Formul., while Average management risk is found at Ganga Pharma. Below Average management risk is noted at Ortin Global, Beryl Drugs, Brawn Biotech, Vivanza Biosci., Decipher Labs, and Fabino Enter. Growth is Below Average for Ortin Global, Beryl Drugs, Brawn Biotech, and Decipher Labs, while Average growth is seen at Vivanza Biosci. Ganga Pharma. has Average capital structure, while Good capital structure is noted at Unjha Formul. The rest have Below Average capital structure, including Ortin Global, Beryl Drugs, Brawn Biotech, Vivanza Biosci., and Decipher Labs.Return Snapshot: Unjha Formul. has the highest 1-year return at 10.70%, while Decipher Labs has the lowest at -48.50%. Triochem Product's 1-year return is not available for comparison. Additionally, the six-month returns for Vivanza Biosci., Decipher Labs, and Brawn Biotech are negative.

Q: How big is Triochem Product?

As of 31st March, Triochem Products Ltd has no available market capitalization value, which means it cannot be classified into any market cap type.In the latest four quarters, the company reported net sales of 0.00 Cr and a net profit of 8.10 Cr. This indicates that while there were no sales, the company did achieve a profit during this period.The reporting period for the balance sheet is as of March 2026, with shareholder's funds amounting to 20.65 Cr and total assets valued at 20.88 Cr. This reflects the financial position of the company at that time.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Jun 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

68.65%

Why is Triochem Products Ltd falling/rising?

02-Sep-2026

As of 01-Sep, the stock price of Triochem Products Ltd is at 17.40, showing no change and a 0.00% performance over the past week and month. The stock is significantly underperforming the sector, trading below moving averages, and exhibiting erratic trading patterns, indicating a bearish trend.

View full answer

Who are in the management team of Triochem Product?

01-Sep-2026

The management team of Triochem Product includes Ramu S Deora (CEO), Sunil S Jhunjhunwala (Independent Director), S S Sharma (Director), Girish Kumar Pungalia (Independent Director), Rajesh Ramu Deora (Director), Ureca Shirish Shirole (Company Secretary), and Grace R. Deora (Non-Executive Director).

View full answer

What does Triochem Product do?

01-Sep-2026

Triochem Products Ltd manufactures and exports pharmaceutical products, APIs, and chemicals, operating as a Micro Cap company in the Pharmaceuticals & Biotechnology industry. As of June 2026, it reported a net profit of 0 Cr.

View full answer

Who are the peers of the Triochem Product?

01-Sep-2026

Triochem Product's peers include Unjha Formul., Ortin Global, Beryl Drugs, Brawn Biotech, Ganga Pharma., Vivanza Biosci., Decipher Labs, Shyama Computro., and Fabino Enter. Unjha Formul. shows the best management risk and highest 1-year return at 10.70%, while Decipher Labs has the lowest return at -48.50%.

View full answer

How big is Triochem Product?

01-Sep-2026

As of 31st March, Triochem Products Ltd has no market capitalization and reported net sales of 0.00 Cr with a net profit of 8.10 Cr. Shareholder's funds are 20.65 Cr and total assets are 20.88 Cr as of March 2026.

View full answer

Which are the latest news on Triochem Product?

01-Sep-2026

No latest news for Triochem Product found.

Who are the top shareholders of the Triochem Product?

17-Jul-2025

The top shareholders of Triochem Product include Rajesh Ramu Deora with 14.69%, Ambernath Plasto Packaging Private Limited at 4.9%, and individual investors holding a combined 15.53%. There are no mutual funds or foreign institutional investors currently involved.

View full answer

When is the next results date for Triochem Product?

16-May-2025

No Upcoming Board Meetings

Compare Triochem Product with Similar Stocks

Shyama Computro.Fabino Enter Decipher Labs

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR Cr (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2026)

Net Profit:

0 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizers Report

24-Aug-2026 | Source : BSE

The voting results along with the Scrutinizer Report on thee resolution approved by the Shareholders at the Fifty Four Annual General Meeting of the Triochem Products Limited held on 22nd Augsut 2026 at 03.00 p.m. at ............

Announcement under Regulation 30 (LODR)-Meeting Updates

24-Aug-2026 | Source : BSE

We hereby submit the Annual Report for the FY 2025-26 duly approved and adopted by the members as per provision of the Companies Act 2013 in the Annual General meeting of the Company held on Saturday 22nd August 2026 at 03.00 P.M. at ..............

Shareholder Meeting / Postal Ballot-Outcome of AGM

22-Aug-2026 | Source : BSE

Summary of proceesings pf the AGM of the Compnay as required under Regualtion 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosurer Requirements) Regualtion 2015 (SEBI LODR).

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

No Data Found

Valuation key factors

No Data Found

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rajesh Ramu Deora (14.69%)

Highest Public shareholder

Triochem Laboratories Private Limited (4.9%)

Individual Investors Holdings

15.53%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -98.92% vs 6,507.69% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.04",
          "val2": "-0.22",
          "chgp": "81.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.08",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "11.17",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.09",
          "val2": "8.33",
          "chgp": "-98.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.78",
          "val2": "-0.60",
          "chgp": "-30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.22",
          "val2": "-0.12",
          "chgp": "-83.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.16",
          "val2": "-1.19",
          "chgp": "2.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.35",
          "val2": "-0.03",
          "chgp": "-1,066.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2,092.50% vs 60.40% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.38",
          "val2": "-1.22",
          "chgp": "-13.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.97",
          "val2": "-0.40",
          "chgp": "2,092.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.04

-0.22

81.82%

Interest

0.00

0.08

-100.00%

Exceptional Items

0.00

11.17

-100.00%

Standalone Net Profit

0.09

8.33

-98.92%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -98.92% vs 6,507.69% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.78

-0.60

-30.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.22

-0.12

-83.33%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Standalone Net Profit

Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.16

-1.19

2.52%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.35

-0.03

-1,066.67%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.38

-1.22

-13.11%

Interest

0.08

0.00

Exceptional Items

11.17

0.00

Standalone Net Profit

7.97

-0.40

2,092.50%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 2,092.50% vs 60.40% in Mar 2025

All Annual Results

Company CV

About Triochem Products Ltd

Triochem Products Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Triochem Products Ltd was incorporated in the year January 17, 1972. The Company is engaged in the business of manufacturer and exporter of pharmaceuticals products, API and chemicals.

Company Coordinates

Company Details

Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001

Tel: 91-22-22663150

http://www.triochemproducts.com

investor@triochemproducts.com

Registrar Details

Sharex (India) Pvt Ltd , Unit No.1, Luthra Ind.Premises Andheri Kurla Road, Safed Pool , Mumbai